Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.00 (0.00%)
AAPL  278.78
+0.00 (0.00%)
AMD  217.97
+0.00 (0.00%)
BAC  53.95
+0.00 (0.00%)
GOOG  322.09
+0.00 (0.00%)
META  673.42
+0.00 (0.00%)
MSFT  483.16
+0.00 (0.00%)
NVDA  182.41
+0.00 (0.00%)
ORCL  217.58
+0.00 (0.00%)
TSLA  455.00
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.